US Preventive Services Task Force. Ann Intern Med 2009;150:

Slides:

Advertisements

Similar presentations

1 Understanding How the U.S. Preventive Services Task Force Works USPSTF 101.

Advertisements

BREAST CANCER SCREENING Anoop Agrawal, M.D.. NEW USPSTF BREAST SCREENING GUIDELINES Published by US Preventative Screening Task Force in November 2009.

Plenary III Ask About Aspirin Stanton Shanedling, PhD, MPH Supervisor, Heart Disease & Stroke Prevention Unit, Minnesota.

Mortality benefit from reduction in sodium consumption 1 Hypertension affects one-third of the US population, of which less than half have their blood.

CVD risk estimation and prevention: An overview of SIGN 97.

Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.

Cardiovascular Disease in Women Module VI: Update on Menopausal Hormone Therapy and Selective Estrogen Receptor Modulators (SERMs)

Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.

Should we??. Aspirin is useful! It is widely used in secondary prevention It reduces the yearly risk of vascular events by about a quarter This corresponds.

How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.

10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.

Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.

LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.

HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.

Introduction to Healthcare and Public Health in the US The Evolution and Reform of Healthcare in the US Lecture b This material (Comp1_Unit9b) was developed.

U.S. Preventive Services Task Force’s Recommendations on Aspirin

Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.

The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.

Promoting Breastfeeding to Decrease Type Two Diabetes Development After Gestational Diabetes Sophia Olsen and Dominique Lima, BSN Nursing Student Class.

Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.

Utilizing Biostatistics in Diagnosis, Screening, and Prevention Presentation 3 of 6.

Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.

The Use of Aspirin for Primary Prevention of Cardiovascular Diseases

Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:

Date of download: 6/21/2016 From: Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services.

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis.

Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.

Date of download: 6/26/2016 From: Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services.

Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.

From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):

How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.

From: Screening for Syphilis Infection in Pregnancy: U. S

Copyright © 2012 American Medical Association. All rights reserved.

American Heart Month Resources:

Conflicts of interest Major role in development of GRADE

Copyright © 2011 American Medical Association. All rights reserved.

HOPE: Heart Outcomes Prevention Evaluation study

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

Markov model structure

From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2013;159(10):

United States Preventive Services Task Force: Recommendations for ABPM

From: Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular DiseaseGrand Rounds Discussion From the Beth Israel Deaconess Medical.

AIM HIGH Niacin plus Statin to prevent vascular events

Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.

Non-Viral STD of Major significance

Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.

ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular disease Jane Armitage.

HCV Infection in the United States: What Are We Dealing With?

Antithrombotics and PAD: A New Paradigm in Practice

Cardiovascular disease

Prevalence of statin and beta-blocker use by clinical presentation

Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.

Cardiovascular disease

Aspirin in Cardioprevention:

Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.

Aspirin and Cardioprevention in 2018

Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?

Factor Xa Inhibitors in PAD

FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.

Risk for BMI outcome (%)

Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.

Women’s Health Study: Baseline Characteristics Part 1

Component 1: Introduction to Health Care and Public Health in the U.S.

What is the net force on the object? Will this object move?

Section II: Lipid management

Potential effect of guidelines on ASCVD prevention in the CGPS*

Flow chart of search strategy

Section C: Clinical trial update: Oral antiplatelet therapy

QRISK 3 – Clare Hawley - Summary slide

Presentation transcript:

US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

Estimated MIs prevented and estimated harms of using aspirin for 10 years in a hypothetical cohort of 1000 men US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

10-year CHD risk levels at which the number of cardiovascular disease events prevented is closely balanced to the number of serious bleeding events US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

Estimated number of strokes prevented and estimated harms of using aspirin for 10 years in a hypothetical cohort of 1000 women on the basis of age and 10-year stroke risk US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

Aspirin for the prevention of cardiovascular disease: clinical summary of a U.S. Preventive Services Task Force recommendation statement US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

What the USPSTF Grades Mean and Suggestions for Practice US Preventive Services Task Force. Ann Intern Med 2009;150:396-404

U.S. Preventive Services Task Force Levels of Certainty Regarding Net Benefit US Preventive Services Task Force. Ann Intern Med 2009;150:396-404